- Home
- CCRN vs KURA Comparison
CCRN vs KURA Comparison
Compare CCRN & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- KURA
- Stock Information
- Founded
- CCRN 1986
- KURA 2014
- Country
- CCRN United States
- KURA United States
- Employees
- CCRN N/A
- KURA N/A
- Industry
- CCRN Professional Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCRN Consumer Discretionary
- KURA Health Care
- Exchange
- CCRN Nasdaq
- KURA Nasdaq
- Market Cap
- CCRN 587.1M
- KURA 611.7M
- IPO Year
- CCRN N/A
- KURA N/A
- Fundamental
- Price
- CCRN $18.22
- KURA $7.91
- Analyst Decision
- CCRN Buy
- KURA Strong Buy
- Analyst Count
- CCRN 3
- KURA 11
- Target Price
- CCRN $18.31
- KURA $27.89
- AVG Volume (30 Days)
- CCRN 473.4K
- KURA 1.5M
- Earning Date
- CCRN 02-19-2025
- KURA 02-25-2025
- Dividend Yield
- CCRN N/A
- KURA N/A
- EPS Growth
- CCRN N/A
- KURA N/A
- EPS
- CCRN N/A
- KURA N/A
- Revenue
- CCRN $1,448,099,000.00
- KURA N/A
- Revenue This Year
- CCRN N/A
- KURA N/A
- Revenue Next Year
- CCRN N/A
- KURA $233.30
- P/E Ratio
- CCRN N/A
- KURA N/A
- Revenue Growth
- CCRN N/A
- KURA N/A
- 52 Week Low
- CCRN $9.58
- KURA $6.98
- 52 Week High
- CCRN $22.14
- KURA $24.17
- Technical
- Relative Strength Index (RSI)
- CCRN 73.32
- KURA 40.61
- Support Level
- CCRN $18.17
- KURA $7.52
- Resistance Level
- CCRN $18.26
- KURA $8.26
- Average True Range (ATR)
- CCRN 0.06
- KURA 0.36
- MACD
- CCRN -0.14
- KURA 0.21
- Stochastic Oscillator
- CCRN 60.00
- KURA 71.21
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.